Literature DB >> 24900057

Hepatic FDG Uptake is not Associated with Hepatic Steatosis but with Visceral Fat Volume in Cancer Screening.

Kyoungjune Pak1, Seong-Jang Kim1, In Joo Kim1, Keunyoung Kim1, Heeyoung Kim1, So Jung Kim1.   

Abstract

PURPOSE: We aimed to evaluate the relation between visceral fat volume and fluorodeoxyglucose (FDG) uptake of the liver measured by maximum or mean standardized uptake value.
METHODS: We retrospectively analyzed 96 consecutive records of positron emission tomography/computed tomography (PET/CT) performed for cancer screening between May 2011 and December 2011. Subjects were divided into 2 groups according to Hounsfield unit (HU) of the liver comparing with that of the spleen. The control group (20 women, 56 men) demonstrating HU of the liver equal or greater than that of the spleen included 76 patients, while the fatty liver group (2 women, 18 men) showing HU of the liver less than that of the spleen included 20 patients. We compared FDG uptake of the liver and visceral fat volume between two groups. We evaluated correlation of hepatic FDG uptake measured by maximum or mean standardized uptake value (SUV) with visceral fat volume and attenuation.
RESULTS: The fatty liver disease group showed higher aspartate aminotransferase (AST)of (24.42 ± 7.22, p = 0.012), alanine aminotransferase (ALT) of (25.16 ± 11.68, p = 0.001), body mass index (BMI) of (24.58 ± 3.29, p = 0.021), and visceral fat volume (3063.53 ± 1561.43, p = 0.011) than the control group. There were no statistically significant differences of mean standardized uptake value of the liver (liver SUVmean) (2.73 ± 0.19, p = 0.723), maximum standardized uptake value of the liver (liver SUVmax) (3.39 ± 0.53, p = 0.8248) and liver SUVmean/spleen SUVmean (1.13 ± 0.10, p = 0.081) between the two groups. Strong correlations were shown between liver SUVmean and BMI (r = 0.609, p < 0.001) and between liver SUVmean and visceral fat volume (r = 0.457, p < 0.001). Liver SUVmax was also strongly correlated with BMI (r = 0.622, p = 0.001) and visceral fat volume (r = 0.547, p < 0.001). There was no significant association of mean attenuation value of the liver (liver HUmean) with liver SUVmean (r = -0.003, p = 0.979) or liver SUVmax (r = -0.120, p = 0.244).
CONCLUSION: Hepatic FDG uptake quantified as SUVmean or SUVmax is not correlated with hepatic steatosis but with visceral fat volume in cancer screening.

Entities:  

Keywords:  Fluorodeoxyglucose F18; Liver; Positron-emission tomography; Visceral fat

Year:  2012        PMID: 24900057      PMCID: PMC4043043          DOI: 10.1007/s13139-012-0143-y

Source DB:  PubMed          Journal:  Nucl Med Mol Imaging        ISSN: 1869-3474


  19 in total

1.  Direct measurement of hepatic blood flow in surgical patients: with related observations on hepatic flow dynamics in experimental animals.

Authors:  W G SCHENK; J C McDONALD; K McDONALD; T DRAPANAS
Journal:  Ann Surg       Date:  1962-09       Impact factor: 12.969

2.  A case of diffuse-type primary hepatic lymphoma mimicking diffuse hepatocellular carcinoma.

Authors:  Koichiro Kaneko; Akihiro Nishie; Fumitou Arima; Tsuyoshi Yoshida; Ken Ono; Junichi Omagari; Hiroshi Honda
Journal:  Ann Nucl Med       Date:  2011-01-14       Impact factor: 2.668

Review 3.  Applications of PET in liver imaging.

Authors:  Amir H Khandani; Richard L Wahl
Journal:  Radiol Clin North Am       Date:  2005-09       Impact factor: 2.303

4.  A case of diffuse hepatic angiosarcoma diagnosed by FDG-PET.

Authors:  Ai Oe; Daiki Habu; Joji Kawabe; Kenji Torii; Etsushi Kawamura; Jin Kotani; Takehiro Hayashi; Hiroki Sakaguchi; Susumu Shiomi
Journal:  Ann Nucl Med       Date:  2005-09       Impact factor: 2.668

5.  Variability and reproducibility of hepatic FDG uptake measured as SUV as well as tissue-to-blood background ratio using positron emission tomography in healthy humans.

Authors:  Inge-Lis Kanstrup; Thomas Levin Klausen; Jens Bojsen-Møller; Peter Magnusson; Bo Zerahn
Journal:  Clin Physiol Funct Imaging       Date:  2008-12-04       Impact factor: 2.273

6.  Distribution of adipose tissue and risk of cardiovascular disease and death: a 12 year follow up of participants in the population study of women in Gothenburg, Sweden.

Authors:  L Lapidus; C Bengtsson; B Larsson; K Pennert; E Rybo; L Sjöström
Journal:  Br Med J (Clin Res Ed)       Date:  1984-11-10

Review 7.  Obesity, inflammation, and insulin resistance.

Authors:  Steven E Shoelson; Laura Herrero; Afia Naaz
Journal:  Gastroenterology       Date:  2007-05       Impact factor: 22.682

8.  Visceral fat adipokine secretion is associated with systemic inflammation in obese humans.

Authors:  Luigi Fontana; J Christopher Eagon; Maria E Trujillo; Philipp E Scherer; Samuel Klein
Journal:  Diabetes       Date:  2007-02-07       Impact factor: 9.461

Review 9.  Central role of mitochondria in metabolic regulation of liver pathophysiology.

Authors:  Nobuhiro Sato
Journal:  J Gastroenterol Hepatol       Date:  2007-06       Impact factor: 4.029

10.  Visceral adiposity, fasting plasma insulin, and blood pressure in Japanese-Americans.

Authors:  E J Boyko; D L Leonetti; R W Bergstrom; L Newell-Morris; W Y Fujimoto
Journal:  Diabetes Care       Date:  1995-02       Impact factor: 19.112

View more
  6 in total

1.  Mean standardized uptake value (SUVmean) and global hepatic glycolysis as potential imaging markers reflecting hepatic functional capacity: evidence from 18F-FDG PET/CT.

Authors:  X Yue; J Wang; F Ye; D Xiao
Journal:  Hippokratia       Date:  2018 Oct-Dec       Impact factor: 0.471

2.  A Study of the Feasibility of FDG-PET/CT to Systematically Detect and Quantify Differential Metabolic Effects of Chronic Tobacco Use in Organs of the Whole Body-A Prospective Pilot Study.

Authors:  Drew A Torigian; Judith Green-McKenzie; Xianling Liu; Frances S Shofer; Thomas Werner; Catherine E Smith; Andrew A Strasser; Mateen C Moghbel; Ami H Parekh; Grace Choi; Marcus D Goncalves; Natalie Spaccarelli; Saied Gholami; Prithvi S Kumar; Yubing Tong; Jayaram K Udupa; Clementina Mesaros; Abass Alavi
Journal:  Acad Radiol       Date:  2016-10-18       Impact factor: 3.173

3.  Intra-patient Variability of FDG Standardized Uptake Values in Mediastinal Blood Pool, Liver, and Myocardium during R-CHOP Chemotherapy in Patients with Diffuse Large B-cell Lymphoma.

Authors:  Soo Jeong Kim; Hyun Kyung Yi; Chae Hong Lim; Young Seok Cho; Joon Young Choi; Yearn Seong Choe; Kyung-Han Lee; Byung-Tae Kim; Seung Hwan Moon
Journal:  Nucl Med Mol Imaging       Date:  2016-07-13

4.  Clinical utility of FDG uptake within reticuloendothelial system on F-18 FDG PET/CT for prediction of tumor recurrence in breast cancer.

Authors:  Ji-In Bang; Hai-Jeon Yoon; Bom Sahn Kim
Journal:  PLoS One       Date:  2018-12-07       Impact factor: 3.240

5.  Improvement of liver metabolic activity in people with advanced HIV after antiretroviral therapy initiation.

Authors:  Reema Patel; Maura M Manion; Elizabeth Laidlaw; Paul Wakim; Zeping Wang; Megan Anderson; Frances Galindo; Adam Rupert; Andrea Lisco; Theo Heller; Irini Sereti; Dima A Hammoud
Journal:  AIDS       Date:  2022-08-03       Impact factor: 4.632

6.  Diagnostic Ability of FDG-PET/CT in the Detection of Malignant Pleural Effusion.

Authors:  Reiko Nakajima; Koichiro Abe; Shuji Sakai
Journal:  Medicine (Baltimore)       Date:  2015-07       Impact factor: 1.817

  6 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.